American Association for Thoracic Surgery (AATS) American Association for Thoracic Surgery (AATS)
 
Home | About Us | Contact Us
 
Developing The Academic Surgeon Symposium

Back to Annual Meeting Program


DEVELOPING THE ACADEMIC

SURGEON - A SYMPOSIUM

Saturday, April 17, 1999 1:00 p.m. - 6:00 p.m.

Ernest N. Mortal Convention Center - Room 211/212

Objective

The 1999 Academic Surgeon's Symposium is a new symposium designed to help develop the Academic Cardiothoracic Surgeon. This is a new effort by the American Association for Thoracic Surgery to help provide a specific educational conference for potential and active academic cardiothoracic surgeons. The present Symposium will focus on several areas including time management, developing surgical techniques, research, administrative skills and mentorship.

This Symposium is designed for Residents interested in a career in academic cardiothoracic surgery, junior Faculty in academic institutions, as well as senior Faculty including Division and Department Heads. It is intended that at the completion of this Symposium, participants should have better knowledge regarding developing and teaching academic skills.

Accreditation

The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The American Association for Thoracic Surgery designates this continuing education activity for 4.5 credit hours in Category 1 of the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours he/she spent in the continuing medical education program.


Program

12:00 p.m. LUNCH - Room 213

1:00 p.m. GETTING STARTED

Edward D. Verrier, M.D.

University of Washington, Seattle, Washington

1:30 p.m. CLINICAL RESEARCH

Frederick L. Grover, M.D.

University of Colorado Health Sciences Center

and Denver VAMC, Denver, Colorado

2:00 p.m. TEACHING SURGERY

William A. Baumgartner, M.D.

Johns Hopkins Hospital, Baltimore, Maryland

2:30 p.m. GRANT GETTING

Irving L. Kron, M.D.

Univ. of Virginia Health Sciences Center,

Charlottesville, Virginia

3:00 p.m. DEALING WITH INDUSTRY

Larry R. Kaiser, M.D. Hospital of Univ. of Pennsylvania,

Philadelphia, Pennsylvania

3:30 p.m. BREAK

4:00 p.m. DEVELOPING ADMINISTRATIVE SKILLS

Fred A. Crawford, Jr., M.D.

Medical University of South Carolina,

Charleston, South Carolina

4:30 p.m. SURGICAL INNOVATION

Tirone E. David, M.D.

Toronto General Hospital,

Toronto, Ontario, Canada

5:00 p.m. BECOMING A SURGICAL LEADER

Lawrence H. Cohn, M.D. Brigham & Womens Hospital,

Boston, Massachusetts

5:30 p.m. MENTORSHIP

Floyd D. Loop, M.D.

Cleveland Clinic, Cleveland, Ohio

6:00 pm - 7:30 p.m. RECEPTION - Room 213


CONGENITAL HEART DISEASE SYMPOSIUM

SUNDAY, April 18, 1999 8:00 a.m. - 5:00 p.m.

Ernest N. Mortal Convention Center - Room 208/209

Objective

The 1999 AATS Congenital Heart Disease Symposium will address six specific topics, each carefully selected for its controversial nature or evolving status. This year the format of the program will be substantially expanded. Each topic will be specifically addressed under a different format to enhance the particular issues related to that topic. Two of the topics will be presented as "in-depth sessions" each consisting of three separate presentations. These presentations will address surgical technique, decision making and timing of management, and evolving understanding of pathophysiology. The two topics which will be presented using the "in-depth sessions" format will be:

1. Management of the right ventricular outflow tract following prior Tetralogy of Fallot repair, and

2. Management of anomalous coronary artery arising from the pulmonary artery.

Three other topics will be presented using a point- counter point format. In each of these sessions two carefully chosen experts will present opposite sides of the controversial issue, followed by an expanded moderator-led discussion period between the audience and the two speakers. The topics chosen for point- counter point presentations will include:

1. The use and efficacy of deep hypothermic circulatory arrest,

2. Management of critical neonatal aortic stenosis, and

3. Surgical management of complex congenital heart lesions which have two ventricles and two atrio- ventricular valves.

The final topic will be presented as a panel discussion. In this session each of five carefully chosen experts will present a five minute overview of the topic from their particular perspective and then an expanded moderator led panel discussion among the experts, with audience involvement, will follow. The subject of this session will be the use of ultrafiltration in Pediatric Cardiac Surgery. At the completion of the symposium participants should have an enhanced understanding of these evolving and controversial areas of congenital heart disease with respect to pathophysiology, management options, and timing of intervention.


Accreditation

The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The American Association for Thoracic Surgery designates this continuing education activity for 6.5 credit hours in Category 1 of the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours he/she spent in the continuing medical education program.

Program

7:00 a.m. REGISTRATION AND CONTINENTAL BREAKFAST

8:00 a.m. INTRODUCTION AND WELCOME

Frank L. Hanley, M.D., Chairman

SESSION LATE REOPERATION ON THE RIGHT VENTIRCULAR OUTFLOW TRACT IN REPAIRED TETRALOGY OF FALLOT

Moderator: Edward L. Bove, M.D.

8:05 a.m. CRITERIA AND TIMING FOR RE-INTERVENTION

William G.Williams, M.D.

Hospital for Sick Children and Toronto Congenital Cardiac Center for Adults, Univ. of Toronto,

Toronto, ON, Canada

8:25 a.m. RIGHT VENTRICULAR PHYSIOLOGY IN REPAIRED TETRALOGY OF FALLOT

Andrew Redington, M.D.

Royal Brompton & Harefield NHS Trust, London, United Kingdom

8:45 a.m. SURGICAL TECHNIQUES FOR REVISING THE RIGHT VENTRICULAR OUTFLOW TRACT

Edward L. Bove, M.D. University of Michigan Hospital,

Ann Arbor, Michigan

9:05 a.m. DISCUSSION PERIOD

SESSION II MANAGEMENT OF ANOMALOUS CORONARY ARTERIES ARISING FROM PULMONARY ARTERY

Moderator: Hillel Laks, M.D.

9:30 a.m. THE PHYSIOLOGY OF STUNNED AND HIBERNATING MYOCARDIUM

Shahbudin Rahimtoola, M.D. University of Southern California

Los Angeles, California

9:50 a.m. SURGICAL OPTIONS FOR REPAIR AND TECHNIQUE OF MYOCARDIAL PROTECTION

Hillel Laks, M.D.

University of California at Los Angeles, Los Angeles, California

10:10 a.m. LONG TERM OUTCOME AND VENTRICULAR FUNCTION FOLLOWING REPAIR

Tom R. Karl, M.D. Royal Childrens Hospital Melbourne, Australia

10:30 a.m. DISCUSSION PERIOD

10:50 a.m. COFFEE BREAK

SESSION III POINT-COUNTERPOINT PANEL DEEP HYPOTHERMIC CIRCULATORY ARREST

Moderator: Marc R. de Leval, M.D.

11:15 a.m. Deep Hypothermic Circulatory Arrest Remains Useful as a Routine in Pediatric Heart Surgery

Thomas L. Spray, M.D.

The Children's Hospital of Philadelphia, University

of Pennsylvania, Philadelphia, Pennsylvania

11:30 a.m. Deep Hypothermic Circulatory Arrest Can and Should be Avoided Completely in Pediatric Heart Surgery

V. Mohan Reddy, M.D.

University of California at San Francisco

San Francisco, California

11:45 a.m. DISCUSSION AND DEBATE

12:15 p.m. LUNCHEON

SESSION IV POINT-COUNTERPOINT PANEL SURGICAL MANAGEMENT OF COMPLEX CONGENITAL HEART DISEASE WITH TWO VENTRICLES AND TWO AV VALVES

Moderator: V. Mohan Reddy, M.D.

1:30 p.m. The Fontan Operation is the Procedure of Choice

Marc R. de Leval, M.D. Hospital for Sick Children London, United Kingdom

1:45 p.m. Complex Two Ventricle Repair is the Procedure of Choice

Michel N. Ilbawi, M.D.

University of Illinois at Chicago, Chicago, Illinois

2:00 p.m. DISCUSSION AND DEBATE

SESSION V POINT-COUNTERPOINT PANEL MANAGEMENT OF CRITICAL NEONATAL AORTIC STENOSIS

Moderator: Thomas L Spray, M.D.

2:30 p.m. Balloon Valvotomy is the Procedure of Choice

Robert H. Beekman, in, M.D. Children's Hospital Medical Center Cincinnati, Ohio

2:45 p.m. The Ross Operation is the Procedure of Choice

Frank L. Hanley, M.D.

University of California at San Francisco

San Francisco, California

3:00 p.m. DISCUSSION AND DEBATE

3:30 p.m. COFFEE BREAK

SESSION VI ULTRAFILTRATION IN PEDIATRIC CARDIAC SURGERY PANEL DISCUSSION

Moderator: Frank L Hanley, M.D.

Panelists:

Martin J. Elliott, M.D.

Hospital for Sick Children, London, United Kingdom

Hanni Hennein, M.D.

Loyola University Medical Center, Maywood, Illinois

Richard A. Jonas, M.D.

Children's Hospital, Boston, Massachusetts

LeNardo Thompson, M.D.

University of California at San Francisco,

San Francisco, California

Ross M. Ungerleider, M.D.

Duke University Medical Center,

Durham, North Carolina

5:00 p.m. ADJOURN

5:00 p.m. WELCOMING RECEPTION-

EXHIBIT HALL


GENERAL THORACIC SURGERY

SYMPOSIUM

Sponsored in cooperation with The General

Thoracic Surgical Club

SUNDAY, April 18, 1999 8:00 a.m. - 5:30 p.m.

Ernest N. Mortal Convention Center - Room 210

Objective:

The intent of this course is to present the practicing thoracic surgeon with an array of exciting new technologies that will shape the care of thoracic patients as we begin the next millennium. Topics include advances in the application of minimally invasive surgery such as Nissen fundoplication, myotomy, photodynamic therapy and volume reduction, as well as multimodality therapies for lung cancer and esophageal disease. Great care has been taken to evaluate and select topics that appear to be those new therapies that will soon be in the therapeutic armamentarium of the practicing thoracic surgeon. It is hoped that by attending this course and gaining an exposure to these new technologies and therapies, thoracic surgeons will incorporate these approaches into their surgical practice in tandem with other medical specialists. The course is envisioned to give the thoracic surgical community as "heads up" regarding these emerging and promising approaches. These topics will be presented in an interactive format in order to maximize the educational experience of course registrants. An expanded syllabus will accompany the course as well.

The Faculty has been selected based on their leadership position in each of the areas to be discussed as well as their track record in incorporating these new approaches into their clinical practice. Interactions with faculty by course registrants will be maximized during this one-day course.

Accreditation

The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The American Association for Thoracic Surgery designates this continuing education activity for 7.5 credit hours in Category 1 of the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours he/she spent in the continuing medical education program.


Program

8:00 a.m. INTRODUCTION: David J. Sugarbaker, M.D., Chairman

SESSION I MINIMALLY INVASIVE THORACIC SURGERY

Moderator: Paul F. Waters, M.D.

8:15 a.m. INTERACTIVE CASE PRESENTATION - ESOPHAGUS

†John R. Roberts, M.D.

Vanderbilt University Hospital,

Nashville, Tennessee

8:25 a.m. LAPROSCOPIC NISSEN FUNDOPLICATION

Keith S. Naunheim, M.D.

St. Louis University Medical Center,

St. Louis, Missouri

8:50 a.m. ENDOSCOPIC MYOTOMY IN ACHALASIA

Tom R. DeMeester, M.D.

USC School of Medicine,

Los Angeles, California

9:15 a.m. PHOTODYNAMIC THERAPY IN BARRETTS ESOPHAGUS

‡Jacques Van Dam, M.D., Ph.D.

Brigham & Women's Hospital,

Boston, Massachusetts

9:40 a.m. THORACOSCOPIC LVRS

Robert J. Keenan, M.D.

University of Pittsburgh Medical Center,

Pittsburgh, Pennsylvania

10:05 a.m. PANEL DISCUSSION

10:25 a.m. COFFEE BREAK

SESSION II THORACIC ONCOLOGY

Moderator: Thomas R. J. Todd, M.D.

11:00 a.m. INTERACTIVE CASE PRESENTATION -

STAGE I LUNG CANCER

Michael Liptay, M.D.

Evanston Hospital, Evanston, Illinois

11:10 a.m. LIFE BRONCHOSCOPY

*Stephen Lam, M.D.

University of British Columbia,

Vancouver, BC, Canada

11:35 a.m. MOLECULAR SUB-STAGING IN STAGE I LUNG CANCER

Malcolm M. DeCamp, Jr., M.D.

Cleveland Clinic Foundation, Cleveland, Ohio

12:05 p.m. INDUCTION THERAPY IN STAGE I NSCLC

Paul Bum, M.D.

University of Colorado Cancer Center,

Denver, Colorado

12:35 p.m. PANEL DISCUSSION

1:00 p.m. LUNCHEON

SESSION III ESOPHAGEAL CANCER

Moderators: Harold C. Urschel, Jr., M.D. and

Scott J. Swanson, M.D.

2:00 p.m. INTERACTIVE CASE PRESENTATION - ESOPHAGEAL CANCER

Kemp Kernstine, M.D., Ph.D.

The University of Iowa,

Iowa City, Iowa

2:10 p.m. PRE-RESECTION STAGING IN ESOPHAGEAL CANCER

Mark J. Krasna, M.D.

University of Maryland, Baltimore, Maryland

2:35 p.m. INDUCTION THERAPY-WHO BENEFITS?

Robert J. Mayer, M.D.

Dana-Farber Cancer Institute

Boston, Massachusetts

3:05 p.m. VATS ESOPHAGECTOMY -DEAD OR ALIVE?

David Harpole, M.D.

Duke University Medical Center,

Durham, North Carolina

3:30 p.m. PANEL DISCUSSION

4:00 p.m. COFFEE BREAK

SESSION IV FUTURE THERAPIES IN THORACIC ONCOLOGY

Moderator: Larry R. Kaiser, M.D.

4:30 p.m. Stage III B LUNG CANCER METASTATIC TO THE PLEURA

Joseph S. Friedberg, M.D.

University of Pennsylvania Medical Center,

Philadelphia, Pennsylvania

4:40 p.m. GENE REPLACEMENT FOR LUNG CANCER

+JackA.Roth,M.D.

M.D. Anderson Cancer Center, Houston, Texas

5:05 p.m. ROBOTICS

#Michael J. Mack, M.D.

Medical City Dallas Hospital,

Dallas, Texas

5:30 p.m. QUESTIONS & ANSWERS

5:45 p.m. ADJOURN

7:00 p.m. WELCOMING RECEPTION IN EXHIBIT HALL

† Author has a relationship with Bristol-Meyers Squibb

‡ Author has a relationship with Sanofi Pharmaceuticals, Inc

* Author has a relationship with LBFE-Lung-Xillix Technologies

+ Author has a relationship with Intragen Therapeutics

# Author has a relationship with Computer Motion


ADULT CARDIAC SURGERY

SYMPOSIUM

SUNDAY, APRIL 18, 1999 8:00 a.m. - 5:00 p.m.

Ernest N. Mortal Convention Center - Ballroom

Objective:

The 1999 Adult Cardiac Surgery Symposium will focus on new areas in cardiac surgery. It is divided into two sessions. The first session will pertain to both brain and spinal cord protection in various surgical settings including minimally invasive surgery, valvular heart surgery, coronary bypass surgery, and surgery on the thoracic aorta. The second session will relate to various types of cardiac surgical remodelling to treat congestive heart failure.

The Symposium is designed for the practicing cardiac surgeon. At the completion of the symposium, the participants should have knowledge of mechanisms of neurologic injury during cardiac surgery as well as treatment options to reduce these complications. They should also have a better understanding of the various techniques available to restore the left ventricle in patients with congestive heart failure.

Accreditation

The American Association for Thoracic Surgery is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The American Association for Thoracic Surgery designates this continuing education activity for 6.5 credit hours in Category 1 of the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours he/she spent in the continuing medical education program.


Program

7:00 a.m. REGISTRATION AND CONTINENTAL BREAKFAST

8:00 a.m. INTRODUCTION:

Irving L. Kron, M.D., Chairman

SESSION I PREVENTION OF NEUROLOGIC INJURY DURING CARDIAC SURGERY

8:00 a.m. Mechanisms and Potential Solutions of Neurologic Injury

John W. Hammon, M.D.

Wake Forest University

School of Medicine

Winston-Salem, North Carolina

8:20 a.m. Avoiding Stroke by Avoiding Bypass

Robert W. Emery, M.D.

Cardiac Surgical Associates

Minneapolis, Minnesota

8:40 a.m. Avoiding Stroke During Port-Access CABG

Mark A. Groh,M.D.

Ashville, North Carolina

9:00 a.m. Avoiding Stroke During Minimally Invasive Valve Surgery

†W. Randolph Chitwood, Jr., M.D.

East Carolina University

School of Medicine

Greenville, North Carolina

9:20 a.m. The Case for Combined Carotid and Coronary Artery Surgery

Gary W.Akins, M.D.

Massachusetts General Hospital

Boston, Massachusetts

9:40 a.m. PANEL DISCUSSION

10:10 a.m. COFFEE BREAK

10:30 a.m. Pathophysiologic Mechanisms of Central Nervous System Injury Involved in Hypothermic Circulatory Arrest

William A. Baumgartner, M.D.

Johns Hopkins Hospital

Baltimore, Maryland

10:50 a.m. The Atherosclerotic Aorta - The Role of Echocardiography

Jeffrey P. Gold, M.D.

The Albert Einstein College of Medicine

Bronx, New York

11:10 a.m. Aortic Dissection

John A. Elefteriades, M.D.

Yale University School of Medicine

New Haven, Connecticut

11:30 a.m. PANEL DISCUSSION

12:15 a.m. LUNCHEON

SESSION II PREVENTION OF SPINAL CORD INJURY IN THORACIC AORTIC ANEURYSM

1:00 p.m. Mechanisms of Spinal Cord Injury

John A. Kern, M.D.

University of Virginia

Charlottesville, Virginia

1:20 p.m. Left Atrial to Femoral Bypass vs. Circulatory Arrest

Joseph S. Coselli, M.D.

Baylor College of Medicine,

The Methodist Hospital

Houston, Texas

1:40 p.m. Is Spinal Cord Injury a Preventable Complication?

M. Arisan Ergin, M.D.

Mt. Sinai Medical Center

New York, New York

2:00 p.m. Clamp and Sew

Irving L. Kron, M.D.

University of Virginia

Health Sciences Center

Charlottesville, Virginia

2:20 p.m. Central and Spinal Cord Neurological Complications with Endovascular Stent Grafts

‡D. Craig Miller, M.D.

Stanford University Medical Center

Stanford, California

2:40 p.m. PANEL DISCUSSION

3:00 p.m. COFFEE BREAK

SESSION III VENTRICULAR RESTORATION

3:20 p.m. Basic Concepts

Gerald D. Buckberg, M.D.

UCLA Medical Center

Los Angeles, California

3:40 p.m. The Endoventricular Circular Patch Plasty

Vincent Dor, M.D.

Centre Cardio-Thoracique

Monaco, Cedex, Monaco

4:00 p.m. The Batista Procedure

Patrick M. McCarthy, M.D.

Cleveland Clinic

Cleveland, Ohio

4:20 p.m. Mitral Repair in Cardiomyopathy

Steven F. Bolling, M.D.

University of Michigan

Ann Arbor, Michigan

4:40 p.m. PANEL DISCUSSION

5:00 p.m. ADJOURN

5:00 p.m.- 7:00 p.m.

WELCOMING RECEPTION IN EXHIBIT HALL

† Author has a relationship with Embolex

‡ Author has a relationship with Meadox Medicals/Boston Scientific Corporation (Boston Scientific Vascular)

 
   Home | About Us | Contact Us | Policies
Copyright© American Association for Thoracic Surgery.
All rights reserved. IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.